Table 4.
Evaluation | Group | N | Average ± SD | CI 95% for the average | % change | P** |
---|---|---|---|---|---|---|
Before treatment | 10 mg | 35 | 263 ± 471 | 78–306 | – | 0.073 |
5 mg | 35 | 115 ± 100 | 42–249 | – | ||
9 months’ treatment | 10 mg | 34* | 90 ± 77 | 9–165 | 65.8% ↓ | 0.035 |
5 mg | 31 | 55 ± 41 | 24–118 | 52.2% ↓ | ||
Follow-up at 9 months | 10 mg | 29 | 196 ± 118 | 132–217 | 25.5% ↓ | 0.066 |
5 mg | 16 | 130 ± 94 | 84–277 | 13.0% ↑ | ||
Follow-up at 18 months | 10 mg | 12 | 255 ± 156 | 135–375 | 3.0% ↓ | 0.190 |
5 mg | 9 | 169 ± 86 | 84–223 | 46.9% ↑ |
Notes: *One fibroid was not measurable;
**t-test.
Abbreviations: CI, confidence interval; SD, standard deviation.